Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
heading into bullish territory here
nHOD .95 :)
Spread has tightened up dramatically and is proving SEWE is worth investing in. Now @ .87 x .90 up +3.45% w/ 25,700 in volume this afternoon. I hope those who entered, held their position; SEWE is heading in a great direction w/ positive movement. All buys comming on the offer now @.90 Look for SEWE to continue to do well IMO.
GLTA.
PR this morning...
Ingen Takes Final Steps Towards Increased Export Sales
ISO Auditor Approves Stage-I for Ingen
.Companies:Ingen Technologies, Inc..Press Release Source: Ingen Technologies, Inc. On Tuesday February 9, 2010, 8:15 am
YUCAIPA, Calif., Feb. 9, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading manufacturer of respiratory medical devices, recently announced today that the company was granted approval of the Stage-I audit conducted by BSI America, Inc. on February 5, 2010.
On February 5, 2010 the company was audited by Mr. Brian Nguyen, one of the certified auditors with BSI America, Inc. According to Mr. Nguyen, Ingen's management system documentation meets the requirements of the ISO 13485:2003, the MDD 93/42/EEC Annex V (M5), and the CMDR. The internal audits and management review processes are being planned and performed. Based on the objective evidences noted from the areas assessed during this Stage-I audit, it is recommended that Ingen proceed to the final Stage-II audit. There were no outstanding non-conformities to review from previous assessments. No new non-conformities were identified during the assessment.
Ingen Technologies is strongly committed to the success of this company and continues driving forward in a direction that is within the best interest of its shareholders. The company has pending back-orders for export sales to China, Japan, Canada, Europe and Australia. Ingen has seen an increase in the value with its intellectual property, research & development, new medical product lines, inventory and other assets, while revenues show a steady incline. ISO Certification is expected to result in a large revenue jump of the company's respiratory product lines.
http://www.bsiamerica.com/
http://www.emergogroup.com/services-by-region/usa
http://www.ingen-tech.com/
took position..time to hold on and hopefully ride that wave to shore
ah there we go..finally getting some action..spread still wide but definitely starting to close the gap..trading @.85 and +6.25%
Keep an eye on the play
ugh gotta tighten that spread
smart move. BGEM to do well with yesterdays PR breaks. Currently up +20.80% and way over the 10 day w/ over 5+M in volume
big day today? opinions?
let's watch this run and head north today
new PR should get this one rolling..
Truesport Alliances, Ltd. Names Eddie Wenrick as Interim CEO
.Press Release Source: Truesport Alliances, Ltd. On Monday January 25, 2010, 11:29 am
LAS VEGAS, NV--(Marketwire - 01/25/10) - Truesport Alliances, Ltd. (OTC.BB:SEWE - News) has named entertainment business executive to lead Truesport Alliances, Ltd., a mixed martial arts (MMA) company, as it continues its growth of the Company's exclusive international TapouT Training Center licenses and manufacturing of MMA equipment.
Truesport Alliances, Ltd.'s board of directors announced the appointment of Mr. Wenrick to serve as interim CEO of Truesport Alliances, Ltd. Mr. Wenrick will be engaged in early financing actions, support of partnering contracts and recruiting of additional management team members. Mr. Wenrick will serve as interim CEO for the next three months. Truesport Alliances, Ltd. is in negotiations to have a formal long-term contract in place with Mr. Wenrick prior to the expiration of the three month term.
Prior to joining Truesport Alliances, Ltd., Mr. Wenrick, a 30-year veteran of the music and entertainment industry, served as CEO and President of Hitlab.com and was responsible for the advancement of online talent and development of new entertainment based technology. Mr. Wenrick has also been instrumental in the coordination and operation of entertainment companies, theaters, concerts and talent management worldwide.
About Truesport Alliances, Ltd.
Truesport Alliances, Ltd. is the premier logistic marketer of branded concepts and equipment, partnering with mixed martial arts (MMA) industry leaders. Embedded with the explosive growth MMA sport, the Company's current clientele base includes the industry's top brands such as UFC, TapouT, Strikeforce and Gold's Gym. Visit the Truesport Alliances, Ltd. website at www.truesportltd.com.
looking bullish..MACD heading north..PR could set PMDP up for a big day come Monday IMO
CSLI closed @ .0068 sitting just above the 20 day MA.a run with the press release we could possibly see a push thru the next resistance .009
IGNT closed @ .002 looking to break next resistance of .0021 (50 day MA). Over the last two weeks of trading, IGNT HOD has reached anywhere between .023-.032; hopefully we continue to see this trend to see some price appriciation.
News this morning...
Ingen CEO Interview on The Money Channel
Increase Sales of the Oxyview Product Line Through GPO Contracts
Buzz up! 0 Print..Companies:Ingen Technologies, Inc..Related Quotes
Symbol Price Change
IGNT.PK 0.0020 0.0000
{"s" : "ignt.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""} Press Release Source: Ingen Technologies, Inc. On Friday January 15, 2010, 7:15 am EST
YUCAIPA, Calif., Jan. 15, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading manufacturer of respiratory medical devices, recently announced that they will engage Medical Strategies International (MSI) to increase sales of the Oxyview product line through GPO contracts. The company points to the increasing prevalence of respiratory diseases, emerging hospital markets, and developing world markets. The CEO will discuss this with host Steve Crowley today at 9:34AM eastern standard time on the world renowned Money Channel's American Scene Radio.
The company projects that the Oxyview Nasal Cannula will bring $10M in revenues, and the new Oxyview Pulse Oximeter an additional $1M in revenues in 2010.
QPRJ
indicators are still showing signals a rally could take place, 50 day is 0.15. IMO, a little profit taking should be expected
just got back to .10 could have a late day rally IMO
nHOD .14 +40% !!
now @.13 ! !!
just pushed to .12 +33%
QPRJ already over 10 day..
awesome day yesterday...should continue with the news this morning..IMO we push through .11 today
nHOD .11 +96% ! ! !
QPRJ doing well today. Recent press release adding towards the positive movement this afternoon. Buys coming in on the offer @.10 nHOD. Now up +78.57% w/ great volume, way over the 10 day average!!
$PLBI After the sell off early today, is now showing a support @ .017 IMO we will see a late rally push to .019 X .022
Regenobody S.A. Obtains License From the Dominican Republic to Harvest, Incubate, and Transplant Stem Cells
.Press Release Source: Proton Laboratories, Inc. On Tuesday January 12, 2010, 10:14 am
SOSUA BAY, Dominican Republic, Jan. 12, 2010 (GLOBE NEWSWIRE) -- Proton Laboratories, Inc. (Pink Sheets:PLBI - News), through the newly acquired Regenobody S.A, has obtained a license, through LifeXtension Worldwide, from the Government of the Dominican Republic for harvesting, incubating, and transplanting stems cells.
Armando Casciati, President of Proton Laboratories, Inc., stated; "This is tremendous news for our company. Very rarely are companies licensed by their respective governments to conduct research, harvest, and incubate stems cells while then being able to transplant these cells back to the patients for therapeutic benefit." Regenobody S.A. will be utilizing procedures and equipment obtained through an EXCLUSIVE Caribbean license from its Korean licensor and patent holder, RNL BIO Co. Ltd. Prior to Regenobody S.A. obtaining the EXCLUSIVE Caribbean licensing rights, these procedures were only available in Japan, Korea, and China. More information may be seen at the Company's website www.regenobody.com. Mr. Casciati went on to state that; "We are focused on developing a world class facility with world class equipment, technicians and procedures to allow patients the ability to utilize their own stem cells, mainly obtained through the fatty tissues of the stomach, to improve their lives."
The statements made in this release contain certain forward-looking statements concerning potential developments affecting the business, prospects, financial conditions and other aspects of the company to which this release pertains. The actual results of specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although the statements are based upon the best judgments of management of the company as of the date of this release, significant deviation in magnitude, timing and other factors may result from business risks and uncertainties including without limitation, the company's dependence on third parties, market conditions, technical factors, the availability of outside capital and receipt of revenues, and other factors, many of which are beyond the control of the Company.
$PLBI to continue to move in a positive direction w/ the recent press release. Last trade @ .025 The offer now @ .00275 ..PLBI looking to break the 52 week high of .03. Recent chart information http://stockcharts.com/h-sc/ui?s=PLBI&p=D&b=5&g=0&id=p63575017696
TCHH @ .0004 looking to follow the tread I beleive we see .0005 x .0006 today IMO
PLBI already passing the 10 day average this morning and up +100% atm
New PR making this play move in a positive direction.
Now @.0195 x .02, sitting on some major support here. Recent chart information on PLBI http://stockcharts.com/h-sc/ui?s=PLBI&p=D&b=5&g=0&id=p41002426759
trading yesterday broke trendline @ .0004, negative divergen drawing upside. EOD was up network price. breaking bullish market. showing target price @ .0004 for a quick flip. TCHH is becoming a fast momentum play.
TCHH w/ great volume
got the L2 here of course..
126,308,647 in volume (10 day 14,422,954) was up 66% now back to 33% last trade was a sell @ .0004
bid and the ask .0004 x .0005
Woooo possible rally @.0005 7x over the 10day +33%
all buys since the market opening this morning
good press release http://finance.yahoo.com/news/Plateau-Mineral-Development-pz-3655483938.html/print?x=0
they have had a few the past few days. yesterday PMDP had the highest volume in its stocks' history. expect PMDP to have action all day and possibly closing @.0009 by the end of the day IMO.
alright trading in the green +33% and already passing the volume from yesterday news setting TCHH off :)
NEWS
Photo Release -- Ingen Launches the New Oxyview Pulse Oximeter
Another Giant Leap for Ingen
.Companies:Ingen Technologies, Inc..Press Release Source: Ingen Technologies, Inc. On Wednesday January 6, 2010, 1:36 pm
YUCAIPA, Calif., Jan. 6, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading global Medical Device Manufacturer for the Oxyview Nasal Cannula, focused on the $4B Respiratory market for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today the introduction of the new Oxyview Pulse Oximeter.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6961
The Oxyview Pulse Oximeter is a very important and common device to check patient blood-oxygen saturation (SpO2) level and pulse rate. As a small, compact, simple, reliable and durable physiological monitoring device, the Oxyview Pulse Oximeter greatly enhances patient care, and fits both Adult and Pediatric patients. This small & lightweight design has a measurement range of 70% - 100%, and requires two AAA batteries. It has a Resolution of 1% with a measurement accuracy of 70% - 100%: +/- 3%. Some of the features include a dual color OLED display, display SpO2, PR, Pulse bar and Plethysmogram, 6 display modes, low power consumption, automatic power off, battery-low indicator, and an adjustable brightness feature.
This dynamic new product is the most sophisticated and cost competitive pulse oximeter in the market today. The company is selling the new device for $88.00, and when patients purchase the Oxyview Nasal Cannula they will earn points and receive the new Oxyview Pulse Oximeter at a discount. The market for this device includes the home oxygen patient market and the hospital markets.
"This new device will greatly enhance our revenues with expected sales of $1M in 2010, and increased sales with GSA contracts and our new distribution. The new Oxyview Pulse Oximeter has features that no other oximeter can offer, and the price is far less than that of any other Oximeter in its class," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.
Est Float 2.1B
Outstanding Shares 2.8B
yeaaa IGNT +18% and trading w/ decent volume this morning. only been moving up since the news. http://stockcharts.com/h-sc/ui?s=IGNT&p=D&b=5&g=0&id=p27405557802